Novartis working on pan-coronavirus oral treatment, CEO says https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-working-pan-coronavirus-oral-treatment-ceo-says-2021-12-06/ Novartis last year had signed a deal with Molecular Partners to develop two DARPin-based therapies as potential COVID-19 treatments. A new readout from studies of one of those treatments is expected in January, and the duo will then decide on next steps based on that data, Narasimhan said.